BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16859999)

  • 1. Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1.
    Navarro S; Meza NW; Quintana-Bustamante O; Casado JA; Jacome A; McAllister K; Puerto S; Surrallés J; Segovia JC; Bueren JA
    Mol Ther; 2006 Oct; 14(4):525-35. PubMed ID: 16859999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of iPSCs from genetically corrected Brca2 hypomorphic cells: implications in cell reprogramming and stem cell therapy.
    Navarro S; Moleiro V; Molina-Estevez FJ; Lozano ML; Chinchon R; Almarza E; Quintana-Bustamante O; Mostoslavsky G; Maetzig T; Galla M; Heinz N; Schiedlmeier B; Torres Y; Modlich U; Samper E; Río P; Segovia JC; Raya A; Güenechea G; Izpisua-Belmonte JC; Bueren JA
    Stem Cells; 2014 Feb; 32(2):436-46. PubMed ID: 24420904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
    Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo proliferation advantage of genetically corrected hematopoietic stem cells in a mouse model of Fanconi anemia FA-D1.
    Río P; Meza NW; González-Murillo A; Navarro S; Alvarez L; Surrallés J; Castella M; Guenechea G; Segovia JC; Hanenberg H; Bueren JA
    Blood; 2008 Dec; 112(13):4853-61. PubMed ID: 18812474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical protocol for in vivo selection of hematopoietic stem cells corrected by gene therapy in Fanconi anemia group C.
    Noll M; Bateman RL; D'Andrea AD; Grompe M
    Mol Ther; 2001 Jan; 3(1):14-23. PubMed ID: 11162306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo repopulation ability of genetically corrected bone marrow cells from Fanconi anemia patients.
    Cohen-Haguenauer O; Péault B; Bauche C; Daniel MT; Casal I; Levy V; Dausset J; Boiron M; Auclair C; Gluckman E; Marty M
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2340-5. PubMed ID: 16461901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biallelic inactivation of BRCA2 in Fanconi anemia.
    Howlett NG; Taniguchi T; Olson S; Cox B; Waisfisz Q; De Die-Smulders C; Persky N; Grompe M; Joenje H; Pals G; Ikeda H; Fox EA; D'Andrea AD
    Science; 2002 Jul; 297(5581):606-9. PubMed ID: 12065746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2.
    Ikeda H; Matsushita M; Waisfisz Q; Kinoshita A; Oostra AB; Nieuwint AW; De Winter JP; Hoatlin ME; Kawai Y; Sasaki MS; D'Andrea AD; Kawakami Y; Joenje H
    Cancer Res; 2003 May; 63(10):2688-94. PubMed ID: 12750298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous germ line mutation in exon 27 of murine Brca2 disrupts the Fancd2-Brca2 pathway in the homologous recombination-mediated DNA interstrand cross-links' repair but does not affect meiosis.
    Atanassov BS; Barrett JC; Davis BJ
    Genes Chromosomes Cancer; 2005 Dec; 44(4):429-37. PubMed ID: 16127665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2.
    Hussain S; Wilson JB; Blom E; Thompson LH; Sung P; Gordon SM; Kupfer GM; Joenje H; Mathew CG; Jones NJ
    DNA Repair (Amst); 2006 May; 5(5):629-40. PubMed ID: 16621732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymic model for examining BRCA2 expression and function.
    Flores KG; McAllister KA; Greer PK; Wiseman RW; Hale LP
    Mol Carcinog; 2002 Nov; 35(3):103-9. PubMed ID: 12410562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired removal of DNA interstrand cross-link in Nijmegen breakage syndrome and Fanconi anemia, but not in BRCA-defective group.
    Tsuchida K; Komatsu K
    Cancer Sci; 2008 Nov; 99(11):2238-43. PubMed ID: 18771529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Fanconi anemia/BRCA genes in zebrafish sex determination.
    Rodríguez-Marí A; Postlethwait JH
    Methods Cell Biol; 2011; 105():461-90. PubMed ID: 21951543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-linker-sensitive myeloid leukemia cell line from a 2-year-old boy with severe Fanconi anemia and biallelic FANCD1/BRCA2 mutations.
    Meyer S; Fergusson WD; Oostra AB; Medhurst AL; Waisfisz Q; de Winter JP; Chen F; Carr TF; Clayton-Smith J; Clancy T; Green M; Barber L; Eden OB; Will AM; Joenje H; Taylor GM
    Genes Chromosomes Cancer; 2005 Apr; 42(4):404-15. PubMed ID: 15645491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations.
    Myers K; Davies SM; Harris RE; Spunt SL; Smolarek T; Zimmerman S; McMasters R; Wagner L; Mueller R; Auerbach AD; Mehta PA
    Pediatr Blood Cancer; 2012 Mar; 58(3):462-5. PubMed ID: 21548014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice.
    Río P; Segovia JC; Hanenberg H; Casado JA; Martínez J; Göttsche K; Cheng NC; Van de Vrugt HJ; Arwert F; Joenje H; Bueren JA
    Blood; 2002 Sep; 100(6):2032-9. PubMed ID: 12200363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
    Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
    Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of Brca2 exon 27 causes hypersensitivity to DNA crosslinks, chromosomal instability, and reduced life span in mice.
    Donoho G; Brenneman MA; Cui TX; Donoviel D; Vogel H; Goodwin EH; Chen DJ; Hasty P
    Genes Chromosomes Cancer; 2003 Apr; 36(4):317-31. PubMed ID: 12619154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer for the eventual treatment of Fanconi's anemia.
    Liu JM
    Semin Hematol; 1998 Apr; 35(2):168-79. PubMed ID: 9565158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of self-renewal capacity in Fancc-/- stem cells after ex vivo expansion.
    Habi O; Delisle MC; Messier N; Carreau M
    Stem Cells; 2005 Sep; 23(8):1135-41. PubMed ID: 16020692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.